Search

Search Results

• 

  Anticoagulation in obese patients: challenges and strategies

  Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia

  18-09-2025

  https://doi.org/10.4081/btvb.2025.174

  2037

  PDF: 537

  HTML: 306

  XML: 191
• 

  Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

  Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro

  26-01-2026

  https://doi.org/10.4081/btvb.2026.415

  1307

  PDF: 347

  HTML: 165
• 

  Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey

  Stefania Cavazza, Gualtiero Palareti*

  03-10-2025

  https://doi.org/10.4081/btvb.2025.177

  1449

  PDF: 309

  HTML: 206

  Supplementary: 103

• CS04 | Association between elevated plasma levels of tissue plasminogen activator and occult cancer risk: a nested case-cohort analysis in 10,294 healthy subjects S. Bolognini^1,2, C. Ticozzi¹, P. Gomez-Rosas^1,3, L. Russo^1,2, Cj. Tartari^1,2, F. Schieppati^1,2, G. Sampietro⁴, L. Barcella¹, M. Marchetti^1,2, A. Falanga^1,2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, The Netherlands; ⁴Unit of Epidemiology and Statistics, ATS Bergamo, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.201

  696

  PDF: 31
• 

  PO43 | ELEVATED CIRCULATING TISSUE PLASMINOGEN ACTIVATOR LEVELS PREDICT GASTROINTESTINAL AND BREAST CANCER RISK: A PROSPECTIVE NESTED CASE-COHORT STUDY S. Bolognini^1|2, C. Ticozzi¹, P. Gomez-Rosas^1|3, F. Schieppati^1|2, G. Sampietro⁴, L. Barcella¹, M. Marchetti^1|2, A. Falanga^1|2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands; ⁴Unit of Epidemiology and Statistics, ATS Bergamo, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.537

  472

  PDF: 113

• PO061 | LONG-TERM HEADACHE IMPROVEMENT WITH VITAMIN K ANTAGONISTS IN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME: 2-YEAR OBSERVATIONAL COHORT A. Hoxha^1|2, C. Belizna³, E. Esteve-Valverde⁴, A. Prundean⁵, A. Godon⁶, G. Gobbo^1|2, A. Anunciación-Llunell^7|8|9, R. Ferrer-Oliveras¹⁰, J.O. Latino¹¹, S. Udry¹¹, J. Alijotas-Reig^7|8|9 | ¹Department of Medicine, University of Padua, Padova, Italy; ²Internal Medicine Unit, Thrombosis and Bleeding Disorder Center, University Hospital of Padua, Padova, Italy; ³Vascular and Coagulation Department, University Hospital Angers, Angers, France; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵University of Angers, Inserm, CNRS, MITOVASC, SFR ICAT, Angers, France; ⁶Centre Hospitalier Universitaire Angers, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Laboratoire d'Hématologie, Université d'Angers, Nantes Université, Angers, France; ⁷Department of Medicine, Universitat Autònoma de Barcelona, Spain; ⁸Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Spain; ⁹Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca, Barcelona, Spain; ¹⁰Obstetrics Department, High-Risk Unit, Hospital Universitario Quirónsalud, Barcelona, Spain; ¹¹Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.877

  19

  PDF: 10

• CO037 | PERFORMANCE OF A QUALITATIVE POINT-OF-CARE TEST IN PATIENTS EXPERIENCING ACUTE THROMBOEMBOLIC OR MAJOR BLEEDING EVENTS TREATED WITH DOACs: THE T-BLEEDOAC MULTICENTER PROSPECTIVE COHORT STUDY M. Vedovati¹, G. Pepe², S. Vanni³, E. Campello⁴, F. Morello⁵, S. Beccatini¹, D. Giudici¹, F. Lucarini², L. Parmeggiani³, G. Fabiani³, P. Simioni⁴, M. Santoro⁵, P. Nazerian⁶, M. Mosconi¹, C. Becattini¹ | ¹University of Perugia, Perugia, Italy; ²Versilia Hospital, Tuscany North West Health System, Lido di Camaiore (LU), Italy; ³Università di Firenze, Firenze, Italy; ⁴University of Padua, Padova, Italy; ⁵A.O.U. Città della Salute e della Scienza, Torino, Italy; ⁶Careggi University Hospital, Firenze, Italy

  Maria Cristina Vedovati

  26-10-2026

  https://doi.org/10.4081/btvb.2026.739

  29

  PDF: 6
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  https://doi.org/10.4081/btvb.2022.42

  1584

  PDF: 495

• CO008 | ALLOSTATIC LOAD AND THE RISK OF ARTERIAL AND VENOUS VASCULAR EVENTS: A PROSPECTIVE ANALYSIS FROM THE MOLI-SANI STUDY T. Panzera¹, A. Di Castelnuovo¹, M. Bonaccio¹, S. Magnacca¹, A. De Curtis¹, F. Bracone¹, W. Ageno², C. Cerletti¹, M.B. Donati¹, G. de Gaetano¹, L. Iacoviello^1|3, S. Costanzo^1|4 | ¹Research Unit of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy; ²Department of Medicine, University of Padua, Padova, Italy; ³Department of Medicine and Surgery LUM University “Giuseppe Degennaro”, Casamassima, Italy; ⁴Department of Medicine and Surgery, University of Insubria, Varese, Italy

  Teresa Panzera

  26-10-2026

  https://doi.org/10.4081/btvb.2026.710

  33

  PDF: 16

• CO017 | LIFE'S SIMPLE 7 FOR CARDIOVASCULAR HEALTH IS ASSOCIATED WITH LOWER CANCER RISK IN THE MOLI-SANI STUDY M. Bonaccio¹, A. Di Castelnuovo¹, S. Costanzo^1|2, CF. Martinez¹, T. Panzera¹, A. De Curtis¹, S. Magnacca¹, C. Cerletti¹, MB. Donati¹, G. de Gaetano¹, L. Iacoviello^1|3 | ¹Research Unit of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli (IS), Italy; ²Dep. of Medicine and Surgery, University of Insubria, Varese, Italy; ³Dep. of Medicine and Surgery LUM University, Casamassima (BA), Italy

  Marialaura Bonaccio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.719

  25

  PDF: 9

• PO082 | HEMOPHILIA AND LOW BONE MINERAL DENSITY: AN OBSERVATIONAL STUDY D. Fumarulo, R. Corrado, M. Canfora, M. Mazzetti, M. Littera, D. Prisco, C. Tamburini | Internal Medicine, Careggi Hospital, University of Florence, Firenze, Italy

  Daniela Fumarulo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.898

  27

  PDF: 8

• CO076 | ASSOCIATION OF MATRIX METALLOPROTEINASE 2 PLASMA LEVELS WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A NESTED CASE CONTROL STUDY FROM THE ATHERO-AF COHORT D. Menichelli¹, E. Falcinelli², P. Pignatelli³, R. Carnevale^4|5, A. D’Amico⁴, F. Violi², P. Gresele², D. Pastori^4|5, F. Paciullo⁶ | ¹Dip. di Chirurgia Generale e Specialità Chirurgiche Paride Stefanini, Università La Sapienza, Roma, Italy; ²Dip. di Medicina e Chirurgia, Sez. di Medicina Interna Cardiovascolare, Università degli Studi di Perugia, Italy; ³Dip. di Scienze Medico-Chirurgiche e Biotecnologie, Università La Sapienza, Latina, Italy; ⁴IRCCS Neuromed, Pozzilli, Isernia, Italy; ⁵Dip. di Scienze Mediche e Cardiovascolari, Università La Sapienza, Roma, Italy; ⁶Fac. di Medicina e Chirurgia , Vita-Salute San Raffaele University, Milano, Italy

  Francesco Paciullo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.778

  21

  PDF: 8

• CO27 | Intracerebral hemorrhage in hemophilia A and B: a 10-year prospective multicenter study in Italy (2012–2022) E. Zanon¹, A. Napolitano¹, A. Porreca², F. Demartis³, A. Coppola⁴, C. Santoro⁵, I. Cantori⁶, A. C. Molinari⁷, C. Biasioli⁸, M. Luciani⁹, G. Sottilotta¹⁰, B. Pollio¹¹, A. Borchiellini¹², A. Tosetto¹³, P. Flora¹⁴, P. Simioni¹ | ¹Haemophilia Center, First Chair of Internal Medicine, Department of Medicine, University-Hospital of Padua Medical School, Padua; ²Department of Human Sciences and Promotion of the Quality of Life, Unit of Clinical and Molecular Epidemiology IRCCS San Raffaele Roma Open University, Roma; Unit of Clinical and Molecular Epidemiology IRCCS San Raffaele, Roma; ³Centre for Bleeding Disorders, Careggi University Hospital of Firenze; ⁴Azienda Ospedaliero Universitaria di Parma; ⁵Hematology Division, Umberto I University Hospital of Roma; ⁶Haemophilia Center, Department of Transfusion Medicine, Hospital of Macerata; ⁷IRCCS Istituto Giannina Gaslini, Genova; ⁸Haemophilia and Transfusion Centre, Bufalini Hospital, Cesena; ⁹Children’s Hospital Bambino Gesù, Roma; ¹⁰Haemophilia Center, Department of Onco-Hematology and Radioterapy, Hospital of Reggio Calabria; ¹¹Haemophilia Pediatric Center, Transfusion Medicine, City of Health and Science of Turin; ¹²City of Health and Science of Turin; ¹³Hemorrhagic and Thrombotic Diseases Unit, S. Bortolo Hospital of Vicenza; ¹⁴RCCS Foundation Ca’ Granda Maggiore Policlinico Hospital, Milan, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.233

  692

  PDF: 31
• 

  OC02 | INCIDENCE AND PREDICTORS OF ARTERIAL THROMBOSIS IN CANCER PATIENTS: RESULTS FROM THE PROSPECTIVE COMPASS-ARTERIAL CANCER ASSOCIATED THROMBOSIS (COMPASS-ARTECAT) STUDY M. Drakopoulou¹, I. Diamandoulaki², P. Baglaridis¹, P. Las Casa³, P. Van Dreden⁴, K. Toutouzas¹, G. Gerotziafas^4|5 | ¹First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece; ²Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; ³Sorbonne University, INSERM UMR_S_938, CRSA, Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France; ⁴Diagnostica Stago, clinical research, Gennevilliers, France; ⁵Center of Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Ill., USA

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.486

  517

  PDF: 130

• CO054 | ULTRA-PROCESSED FOOD CONSUMPTION IS ASSOCIATED WITH AN INCREASED RISK OF UNPROVOKED VENOUS THROMBOEMBOLISM IN THE MOLI-SANI STUDY M. Bonaccio¹, A. Di Castelnuovo¹, S. Costanzo^1|2, T. Panzera¹, C. Cerletti¹, MB. Donati¹, G. de Gaetano¹, W. Ageno³, L. Iacoviello^1|4 | ¹Research Unit of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli (IS), Italy; ²Dep. of Medicine and Surgery, University of Insubria, Varese, Italy; ³Dep. of Medicine, Università degli Studi di Padova, Padova, Italy; ⁴Dep. of Medicine and Surgery LUM University, Casamassima (BA), Italy

  Marialaura Bonaccio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.756

  27

  PDF: 10

• PO009 | THROMBOPHILIA AND ASSISTED REPRODUCTIVE TECHNOLOGY: PRELIMINARY RESULTS FROM A SINGLE CENTER RETROSPECTIVE COHORT STUDY G. Burrei², E. Malloggi¹, S. Moruzzi¹, L. Delfino¹, F. Pizzolo¹, L. Panepinto¹, F. Presa¹, C. Spillere¹, A. Moschella¹, F. Zoccatelli¹, S. Friso¹, N. Martinelli¹, S. Suardi¹ | ¹Department of Medicine, University Hospital, Verona, Italy; ²General Medicine Unit, Magalini Hospital, Villafranca di Verona, Italy

  Giulia Burrei

  26-10-2026

  https://doi.org/10.4081/btvb.2026.825

  25

  PDF: 9

• CO010 | MAPPING HEMOSTATIC BIOMARKER EXPRESSION ACROSS CANCER TYPES AND STAGES WITHIN THE HYPERCAN COHORT P. Gómez-Rosas^1|2, D. Romeo¹, S. Bolognini¹, C. Ticozzi¹, F. Schieppati^1|4|5, A. D’Alessio³, R. Labianca³, L. Barcella^1|4|5, A. Falanga^3|5, M. Marchetti^1|4|5 | ¹Hospital Papa Giovanni XXIII, Bergamo, Italy; ²Hospital de Oncología, Unidad Médica de Alta Especialidad (UMAE), Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México; ³Fondazione ARTET Onlus, Bergamo, Italy; ⁴ERN EuroBloodNet; ⁵School of Medicine and Surgery, University of Milan Bicocca, Italy. On behalf of the HYPERCAN Investigators

  Marina Marchetti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.712

  36

  PDF: 9
• 

  PO42 | DIFFERENTIAL EXPRESSION OF HEMOSTATIC BIOMARKERS ACROSS CANCER TYPE AND DISEASE STAGE: A PROSPECTIVE ANALYSIS OF 4,292 PATIENTS FROM THE HYPERCAN STUDY P. Gómez-Rosas^1|2|, D. Romeo¹, S. Bolognini¹, C. Ticozzi¹, F. Schieppati¹, A. D’Alessio⁴, R. Labianca⁴, A. Falanga^1|5|6, M. Marchetti^1|5|6 | ¹Hospital Papa Giovanni XXIII, Bergamo, Italy; ²Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; ³Hospital de Oncologia, Unidad Medica de Alta Especialidad (UMAE), Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico; ⁴Fondazione ARTET Onlus, Bergamo, Italy; ⁵ERN EuroBloodNet; ⁶School of Medicine and Surgery, University of Milan Bicocca, Italy; *On Behalf Of The Hypercan Investigators

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.536

  508

  PDF: 110

• CO020 | LEFT ATRIAL ENLARGEMENT AS A MARKER OF ADVERSE CLINICAL OUTCOMES: PRELIMINARY RESULTS OF A PROSPECTIVE COHORT STUDY B. Clerici¹, M. Perego¹, G. Casazza², A.G. Russo³, L. Massironi⁴, A. Moreo⁵, V. Dadone⁶, S. Birocchi¹, F. Bursi⁴, A. Bonelli⁵, P.V. Mattiello¹, F.M. Casanova¹, C. Pisetta¹, M. Scavone¹, M. Guazzi⁴, C. Giannattasio⁵, S. Pierini⁶, G. Agnelli⁷, G.M. Podda¹ | ¹SC Medicina Generale SP, Ospedale San Paolo, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Italy; ²IRCCS Fondazione Ca’ Granda, Policlinico di Milano, Italy; ³SC Unità di Epidemiologia, ATS della Città Metropolitana di Milano, Italy; ⁴SC Cardiologia, Ospedale San Paolo, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Italy; ⁵SC Cardiologia 4, Ospedale Niguarda, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ⁶SC Cardiologia e Unità di Cura Cardiologica (UCC), Ospedale Bassini, ASST Nord Milano, Italy; ⁷SC di Medicina Interna Vascolare e d’Urgenza – Stroke Unit, Università di Perugia, Italy. B. Clerici and M. Perego contributed as co-first authors

  Bianca Clerici

  26-10-2026

  https://doi.org/10.4081/btvb.2026.722

  25

  PDF: 8
• 

  Platelet distribution width is associated with cardiovascular mortality in an adult general population

  Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

  27-09-2023

  https://doi.org/10.4081/btvb.2023.83

  3088

  PDF: 515

  Supplementary Material: 144

• PO04 | Classification criteria for antiphospholipid syndrome: ACR/EULAR 2023 versus Sydney 2006 – A monocentric and retrospective study S. Suardi*, A. Marino*, J. Croce, F. Maiolini, E. Tinazzi, S. Moruzzi, L. Delfino, F. Pizzolo, E. Bassanello, G. Marcassa, C. Spillere, S. Friso, N. Martinelli | *the two authors equally contributed to the work and share the first authorship; Department of Medicine, Section of Internal Medicine, University of Verona, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.266

  630

  PDF: 16
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  https://doi.org/10.4081/btvb.2023.84

  2164

  PDF: 648

  Supplementary File: 289

• CO024 | THE ROLE OF BLOOD CLOTTING AND ENDOTHELIAL ACTIVATION IN THE STRATIFICATION OF BLEEDING AND THROMBOTIC RISK OF ATRIAL FIBRILLATION ON ORAL ANTICOAGULANT THERAPY: INSIGHTS FROM THE STRAT-AF 2 STUDY F. Alfano^1|2, AM. Gori^1|2, A. Bertelli¹, G. Ciarrocca Taranta¹, M. Di Gioia², F. Cesari¹, A. Rogolino¹, A. Sorrentino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Francesco Alfano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.726

  35

  PDF: 11

• CO001 | DERIVATION AND VALIDATION OF THE BLEEPE SCORE FOR RISK STRATIFICATION OF MAJOR BLEEDING IN PATIENTS WITH ACUTE PULMONARY EMBOLISM M. Vedovati¹, L. Cimini¹, V. Valeriano², I. Montenovo¹, A. Murgia³, L. Pierpaoli⁴, G. Tratar⁵, S. Zaccaroni⁶, A. Bongarzoni⁷, A. Vinci¹, A. Mavri⁵, L. Martinelli⁸, G. Pepe⁹, S. Cozzio¹⁰, C. Becattini¹ | ¹University of Perugia, Perugia, Italy; ²Sandro Pertini Hospital, Roma, Italy; ³SS. Annunziata Hospital, Sassari, Italy; ⁴S. Maria delle Croci Hospital, Ravenna, Italy; ⁵University Medical Centre Ljubljana, Ljubljana, Slovenia; ⁶Maggiore Hospital, Bologna, Italy; ⁷ASST Santi Paolo e Carlo-PO San Carlo, Milano, Italy; ⁸Città di Castello Hospital, Città di Castello, Italy; ⁹Versilia Hospital, Tuscany North West Health System, Lido di Camaiore (LU), Italy; ¹⁰Rovereto Hospital, Rovereto, Italy

  Maria Cristina Vedovati

  26-10-2026

  https://doi.org/10.4081/btvb.2026.703

  71

  PDF: 11

• PO20 | Impact of endovascular treatment on functional outcome in ischemic stroke: a real-world retrospective study M.G. Mosconi¹, G. Maraziti¹, M. Paciaroni², J. Fagotti³, V. Caso¹ | ¹Azienda Ospedaliera di Perugia; ²Università degli Studi di Ferrara; ³Ospedale San Giovanni Battista, Foligno (PG), Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.280

  662

  PDF: 18
• 

  PO54 | CANCER-ASSOCIATED THROMBOSIS IN ASPIRIN-TREATED PATIENTS AFTER ARTERIAL THROMBOSIS: THE COMPASS-ARTECAT-ASA PROSPECTIVE COHORT STUDY G. Gerotziafas^1|3|4|5, S. Allakhverdieva⁶, P. Henrique Fernandes Do Carmo Las Casa¹, P. Van Dreden^1|2, J. Fareed³, N. Lomakin⁶ , I. Zotova⁶, L. Buryachkovskaya⁷ | ¹Sorbonne University, INSERM UMR_S_938, CRSA, Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; ²Clinical Research, Diagnostica Stago, Gennevilliers, France; ³Center of Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Chicago, USA; ⁴Thrombosis Center, Department of Obstetrics, Gynecology and Perinatal Medicine, The I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; ⁵VAS-European Independent Foundation in Angiology/Vascular Medicine Milan, Italy; ⁶Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia; ⁷Federal State Budgetary Institution «National Medical Research Centre of Cardiology Named After Academician E. I. Chazov» of the Ministry of Health of the Russian Federation, Moscow, Russia

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.546

  464

  PDF: 104
• 

  Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

  Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

  14-07-2022

  https://doi.org/10.4081/btvb.2022.36

  1693

  PDF: 402

• PO70 | Clinical safety and monitoring of apixaban combined with tacrolimus and everolimus in kidney transplant patients: a prospective study S. Guglielmo¹, E. De Bon², L. Scarano¹, R. Fabris¹, E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ²Thrombotic and Hemorrhagic Disorders Unit, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ³Nephrology and Dialysis Unit, Azienda ULSS 6 Euganea, Cittadella and Camposampiero, Padova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.339

  640

  PDF: 25

• CO015 | EVOLUTION OF ANTICOAGULANT THERAPY FOR CANCER-ASSOCIATED THROMBOSIS: THE START2 REGISTRY ONCO-VTE LONGITUDINAL STUDY M. Marchetti^1|2, T. Zollner^1|2, O.C. Cretu^1|2, A. Chistolini³, R. Pancani⁴, L. Puccetti⁵, P. Sivera⁶, W. Ageno⁷, G. Elmi⁸, V. Fregoni⁹, V. Tonelli¹⁰, E. Antonucci¹¹, D. Poli^11|12, A. Falanga^1|2, L. Barcella^1|2 | ¹Hemostasis & Thrombosis Center, Department of Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy; ²ERN EuroBloodNet; ³Hematology Unit, Department of Translational and Precision Medicine, Sapienza University of Roma, Roma, Italy; ⁴Pulmonary Unit, Hospital of Siena, University of Siena, Siena, Italy; ⁵Hemostasis and Thrombosis Unit, Hospital of Siena, University of Siena, Siena, Italy; ⁶Haematology Unit, Ordine Mauriziano Hospital, Torino, Italy; ⁷Department of Medicine, University of Padua, Padova, Italy; ⁸Department of Medicine, Maggiore Hospital, Bologna, Italy; ⁹Department of Medicine, Sondalo Hospital, Sondalo, Italy; ¹⁰Angiology Unit, Sant'Eugenio Hospital, Roma, Italy; ¹¹Arianna Anticoagulazione Foundation, Bologna, Italy; ¹²Department of Critical Care Medicine, Thrombosis Centre, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

  Marina Marchetti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.717

  39

  PDF: 10

• CO097 | IMPACT OF THE 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CRITERIA IN 1200 WOMEN WITH PRIOR OBSTETRIC ANTIPHOSPHOLIPID SYNDROME J. Alijotas-Reig^1|2|3, E. Esteve-Valverde⁴, L. Saez-Comet⁵, A. Anunciacion-Llunell³, R. Ferrer-Oliveras⁶, E. Lefkou⁷, A. Mekinian⁸, C. Belizna⁹, A. Hoxha¹⁰, A. Tincani¹¹, L. Marozio¹², G. Espinosa¹³, S. de Carolis¹⁴, S. Udry¹⁵, J.O. Latino¹⁵, E. Llurba¹⁶, C.B. Chighizola^17|18, M. Gerosa¹⁹, V. Pengo²⁰, K. Lundelin²¹, P. Rovere-Querini²², V. Canti²², K. Mayer-Pickel²³, T. Reshetnyak²⁴, S. Tabacco²⁵, L. Stojanovich²⁶, B.A. Gonçalves²⁷, S. Morales-Perez¹, F. Miro-Mur³ | ¹Department of Medicine, Universitat Autonoma de Barcelona, Spain; ²Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Spain; ³Systemic Autoimmune Diseases Research Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain; ⁶Obstetrics Department, High-Risk Unit, Hospital Universitario Quironsalud, Barcelona, Spain; ⁷Haematology Unit, Hippokration Hospital of Thessaloniki, Greece; ⁸AP-HP, Hopital Saint-Antoine, Service de Medecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universites, Paris, France; ⁹Vascular and Coagulation Department, University Hospital Angers, Angers, France; ¹⁰Internal Medicine Unit, Thrombotic and Bleeding Disorder Center, University of Padua, Padova, Italy; ¹¹Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy; ¹²Department of Obstetrics and Gynaecology, Universita di Torino, Torino, Italy; ¹³Systemic Autoimmune Diseases Service, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; ¹⁴Department of Gynaecology, Gemelli Hospital, Catholic University, Roma, Italy; ¹⁵Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina; ¹⁶Obstetrics and Gynaecology Department, High-Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ¹⁷Department of Clinical Science and Community Health, University of Milano, Milano, Italy; ¹⁸Unit of Pediatric Rheumatology, ASST G. Pini-CTO, Milano, Italy; ¹⁹Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; ²⁰Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy; ²¹Department of Pediatrics, Faculty of Medicine, University of Turku, Turku, Finland; ²²Internal Medicine and Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; ²³Department of Obstetrics, Medical University of Graz, Graz, Austria; ²⁴Department of Systemic Rheumatic Disease, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia; ²⁵Department of Gynecology, Obstetrics and Urology, Sapienza University of Roma, Roma, Italy; ²⁶University Medical Center, University of Belgrade, Belgrade, Serbia; ²⁷Department of Internal Medicine, Hospital Sant Joan Despí Moises-Broggi, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.799

  25

  PDF: 9

• PO099 | CORRELATION BETWEEN DIRECT ORAL ANTICOAGULANTS PLASMA LEVELS AND BRAIN VASCULAR EVENTS L. Riva¹, M. Paolucci², S. Forlivesi², M. Gentile², G. Casella¹, A. Zini², R. Marcucci³ | ¹UOC Cardiologia Ospedale Maggiore AUSL Bologna, Italy; ²IRCCS Istituto delle Scienze Neurologiche di Bologna UOC Neurologia e Rete Stroke metropolitana Ospedale Maggiore AUSL Bologna, Italy; ³SOD Malattie Aterotrombotiche AOU Careggi Università degli Studi di Firenze, Italy

  Letizia Riva

  26-10-2026

  https://doi.org/10.4081/btvb.2026.915

  23

  PDF: 9

• PO116 | MONOCENTRIC EXPERIENCE OF DOACS REVERSAL MANAGEMENT AT L SACCO HOSPITAL, MILAN: A REAL-WORLD RETROSPECTIVE STUDY A. Veltroni, C. Sitzia, O. Di Bartolo, IM Burgo, MC. Carraro, S. Crivelli, C. Masseroni, GB. Inghilleri | Medicina Trasfusionale, Ospedale L. Sacco, Milano, Italy

  Alessio Veltroni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.932

  19

  PDF: 8
• 

  PO10 | RISK OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS WITH CENTRAL VENOUS CATHETERS: RESULTS FROM THE VIENNA CAT-BLED STUDY B. Sunder-Plassmann ¹, N, Vladic¹, C. Englisch¹, F. Moik^1|3, V. Sunder-Plassmann², A. Berghoff², M. Preusser², I. Pabinger¹, C. Ay¹ | ¹Division of Hematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna, Austria; ²Division of Oncology, Department of Medicine I, Medical University of Vienna; Vienna, Austria; ³Division of Oncology, Department of Internal Medicine, Medical University of Graz; Graz, Austria

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.506

  485

  PDF: 120

• CO039 | CLINICAL SAFETY AND MONITORING OF APIXABAN IN HEMODIALYSIS PATIENTS: A PROSPECTIVE STUDY S. Guglielmo¹, M. Lovisotto¹, E. De Bon², E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine; ²Thrombosis and Haemostasis Unit, Department of Medicine; ³Nephrology and Dialysis Unit, Azienda Ulss 6 Euganea, Cittadella and Camposampiero, Padova, Italy

  Simone Guglielmo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.741

  28

  PDF: 11

• PO25 | Baseline thrombin generation test does not predict thrombotic events in acute leukemia: a monocentric prospective study M. Biglietto, R. Mormile, M.L. Bisegna, A. Laganà, A. L. Faccini, A. Papa, E. Baldacci, C. Santoro, M.S. De Propris, A. Chistolini | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.286

  654

  PDF: 13

• PO130 | HEMORRHAGIC AND THROMBOTIC COMPLICATIONS DURING DOACS TREATMENT: THE IMPORTANCE OF A REGULAR AND PROLONGED FOLLOW-UP D. Barcellona^1|2, A. Mameli², S. Cornacchini², P. Schirru², L. Fenu², V. Casu², F. Marongiu^1|2 | ¹University of Cagliari, Italy; ²Haemostasis and Thrombosis Unit, Azienda Ospedaliero-Universitaria di Cagliari, Italy

  Doris Barcellona

  26-10-2026

  https://doi.org/10.4081/btvb.2026.946

  32

  PDF: 6

• PO043 | MULTICENTRE REAL‑WORLD EXPERIENCE OF EMICIZUMAB PROPHYLAXIS IN AN ITALIAN COHORT OF 49 CHILDREN WITH SEVERE HEMOPHILIA A - EMIPED STUDY L. Pieri¹, B. Pollio², P. Giordano³, G. Lassandro⁴, S. Linari¹, R. Pasquino¹, E. Piellucci¹, MC. Di Stefano¹, F. Demartis¹, R. Fjerza¹, G. Castaman¹ | ¹Center for Bleeding Disorders, Careggi University Hospital, Firenze, Italy; ²Center for Inherited Bleeding and Thrombotic Disorders, Transfusion Medicine, "Regina Margherita" Children Hospital, Torino, Italy; ³Department of Interdisciplinary of Medicine, University of Bari 'Aldo Moro', Bari, Italy; ⁴General and Specialised Pediatrics Unit, "Giovanni XXIII" Hospital, University of Bari, Bari, Italy

  Lisa Pieri

  26-10-2026

  https://doi.org/10.4081/btvb.2026.859

  27

  PDF: 8

• CO114 | ANTI-PS/PT IgM IDENTIFIES AN ANTIGEN-DEFINED SUBSET WITHIN LUPUS ANTICOAGULANT POSITIVITY ASSOCIATED WITH THROMBOTIC PHENOTYPE M. Sacco¹, S. Lancellotti¹, A. Ferretti¹, M. Basso¹, C. Gavotti², A. Ortolan², V.A. Pacucci², P. Calzoni³, L. Puccetti³, R. De Cristofaro^1|4 | ¹Center for Hemorrhagic and Thrombotic Diseases; ²Rheumatology and Clinical Immunology Unit, Fondazione Policl. Univ. Gemelli IRCCS, Roma, Italy; ³Azienda Ospedaliera-Universitaria Senese, Unità specialistica Coagulopatie Trombotiche ed Emorragiche, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, Siena, Italy; ⁴Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.816

  23

  PDF: 7

• PO110 | CLINICAL OUTCOMES AND SURVIVAL OF UNUSUAL SITE VENOUS THROMBOSIS IN PATIENTS WITH AND WITHOUT MYELOPROLIFERATIVE NEOPLASMS: A RETROSPECTIVE SINGLE-CENTER STUDY I. Bertozzi, M.T. Sartori, G. Libralon, M. Zerbinati, A. Galbiati, P. Simioni | Department of Medicine, University of Padova, Italy

  Irene Bertozzi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.926

  24

  PDF: 9

• PO033 | PLATELET COUNT AND PERIPROCEDURAL MAJOR BLEEDING IN CIRRHOTIC PATIENTS UNDERGOING INVASIVE PROCEDURES: INDIVIDUAL PATIENT DATA META-ANALYSIS E. Tarasconi^1|2, E. Pontisso¹, M. Manzoni¹, S. Birocchi¹, B. Clerici¹, E.G. Giannini³, A. Iacobellis⁴, Shalimar⁵, P. Ponzo⁶, F. Giuliante⁷, A. Lauterio⁸, L. Massicotte⁹, N. Cocero¹⁰, V. Ronca¹¹, G.M. Podda^1|2 | ¹S.C. Medicina Generale II, Ospedale San Paolo Polo Universitario, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Italy; ²Dipartimento di Scienze della Salute (DISS), Università degli Studi di Milano, Italy; ³Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Italy; ⁴Department of Gastroenterology and Endoscopy, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; ⁵Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India; ⁶Division of Gastroenterology and Hepatology, Città della Salute e della Scienza Hospital, University of Torino, Italy; ⁷Hepatobiliary Surgery Unit, Foundation and Teaching Hospital Sacred Heart IRCCS A. Gemelli, Catholic University of the Sacred Heart, Roma, Italy; ⁸General Surgery and Abdominal Organ Transplantation, ASST Grande Ospedale Metropolitano Milano Niguarda School of Medicine and Surgery, University of Milan-Bicocca, Milano, Italy; ⁹Department of Anesthesiology, Centre Hôspitalier de l’Université de Montréal- Hôpital Saint-Luc, Montreal, Canada; ¹⁰Senior Consultant, Oral Surgery Section of the Dental School of the University of Torino at the Azienda Ospedaliera Città della Salute e della Scienza of Torino, Italy; ¹¹IRCCS Humanitas Research Hospital, Department of Gastroenterology, Division of Internal Medicine and Hepatology, Milano, Italy. E. Tarasconi and E. Pontisso contributed as co-first authors

  Elisa Tarasconi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.849

  18

  PDF: 7

• BEST-08 | PERIOPERATIVE MANAGEMENT OF CHILDREN WITH MILD FACTOR VII DEFICIENCY UNDERGOING SURGERY: A RETROSPECTIVE COHORT STUDY B. Borsellino¹, T. Martini¹, I. Ricca², B. Pollio¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ²Transfusion Medicine, Ivrea Hospital, Ivrea, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.608

  93

  PDF: 15
• 

  New perspectives for prevention of the post-thrombotic syndrome

  Paolo Prandoni

  22-03-2022

  https://doi.org/10.4081/btvb.2022.20

  2283

  PDF: 662
• 

  PO72 | CATHETER-RELATED THROMBOSIS VS. FIBROBLASTIC SLEEVE. INCIDENCE AND IMPACT IN ONCOLOGICAL AND HEMATOLOGICAL PATIENTS WITH PERIPHERALLY INSERTED CENTRAL CATHETER M. Nunziata¹, S. Mangiacapra¹, F.P. Damiano¹, N. Iuliano¹, V. Iorio¹, R. Natale², L. Santarpia², M. Amitrano¹ | ¹Internal Medicine, A.O.R.N. San Giuseppe Moscati, Avellino, Italy; ²Internal Medicine, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.560

  524

  PDF: 120

• CO-47 | JOINT ULTRASOUND FOLLOW-UP IN PEDIATRIC PATIENTS WITH HEMOPHILIA: A 12-YEAR PROSPECTIVE SINGLE-CENTER EXPERIENCE I. Ricca¹, B. Borsellino^2|3, T. Martini², C. Martinoli⁴, B. Pollio² | ¹Transfusion Medicine, Ivrea Hospital, Ivrea, Italy; ²Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ³Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy; ⁴Department of Health Science DISSAL, University of Genova, Unit of Radiology and IRCCS San Martino Hospital, Genova, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.657

  50

  PDF: 17
• 

  PO30 | LONG-TERM ANTICOAGULANT THERAPY AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN ADVANCED OVARIAN CANCER V. Bitsadze ¹, A. Vorobev ¹, J. Khizroeva ¹, A. Solopova ¹, M. Tretyakova ¹, N. Gashimova ¹, K. Grigoreva ¹, A. Khisamieva ¹, J. Gris ^1|2, I. Elalamy^1|3|4, G. Gerotziafas^1|3|4, A. Makatsariya¹ | ¹Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children’s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; ²Faculty of Pharmaceutical and Biological Sciences, Montpellier University, France; ³Department Hematology and Thrombosis Center, Medicine Sorbonne University, Paris, France; ⁴Hospital Tenon, Paris, France

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.525

  473

  PDF: 98
• 

  PO26 | OUTCOMES OF DIRECT ORAL ANTICOAGULANTS IN UNUSUAL-SITE THROMBOSIS: IMPACT OF ACTIVE CANCER S. Guglielmo¹, M. Lovisotto¹, L. Scarano¹, E. De Bon², S. Barbar² | ¹Internal Medicine, Department of Medicine, Azienda Ulss 6 Euganea, Cittadella (PD), Italy; ²Thrombotic and Hemorrhagic Disorders Unit, Department of Medicine, Azienda Ulss 6 Euganea, Cittadella (PD), Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.521

  517

  PDF: 109

• CO16 | The predictive value of high-sensitivity C-reactive protein for assessing thrombosis risk in non-small cell lung cancer P. Gomez-Rosas^1,2, M. Marchetti^1,3, L. Russo¹, C.J. Tartari¹, S. Bolognini¹, C. Ticozzi¹, F. Schieppati¹, A. D’Alessio⁴, R. Labianca⁵, A. Falanga^1,3 All on behalf of the Hypercan Investigators | ¹Hospital Papa Giovanni XXIII, Bergamo, Italy; ²Cardiovascular Research Institute Maastricht, CARIM, Maastricht University, Maastricht, the Netherlands; ³School of Medicine and Surgery, University of Milan Bicocca, Italy; ⁴University Vita-Salute San Raffaele, Milan, Italy; ⁵Fondazione ARTET Onlus, Bergamo, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.220

  636

  PDF: 16

• CO028 | ASSOCIATION BETWEEN BONE MARROW EDEMA AND JOINT PAIN IN HEMOPHILIC ARTHROPATHY: A RETROSPECTIVE SINGLE-CENTER STUDY R. Gualtierotti^1|2, E. Guido³, J. Acquati Lozej⁴, A. Giachi¹, M. Fassi¹, M.L. Franzone⁵, L.M. Gentile^5|6, S.M. Siboni¹, L.P. Solimeno⁴, F. Peyvandi^1|2 | ¹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; ²Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy; ³Università degli Studi di Milano, Dipartimento di Oncologia ed EmatoOncologia, Milano, Italy; ⁴Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Division of Orthopaedic Surgery and Traumatology, Milano, Italy; ⁵Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Division of Radiology, Milano, Italy; ⁶Università degli Studi di Milano, Dipartimento di Oncologia ed Emato-Oncologia, Milano, Italy

  Marco Fassi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.730

  25

  PDF: 10

• PO019 | LONGITUDINAL COAGULATION PROFILING BY THROMBIN GENERATION AND CIRCULATING MICROVESISCLES OF INDIVIDUALS UNDERGOING GENDER-AFFIRMING HORMONE THERAPY E. Campello, A. Scala, A. Napolitano, C. Simion, C. Bulato, S. Toffanin, S. Gavasso, B. Serena, A. Montagna, A. Garolla, P. Simioni | Department of Medicine, University of Padova, Italy

  Elena Campello

  26-10-2026

  https://doi.org/10.4081/btvb.2026.835

  26

  PDF: 9

• PO051 | ENDOGENOUS THROMBIN POTENTIAL RATIO AS A PREDICTOR OF BIRTHWEIGHT PERCENTILE IN PREGNANCY G. Tiscia¹, F. Cappucci¹, A. de Laurenzo¹, M.P. Palumbo¹, D. Colaizzo¹, E. Grandone^1|2 | ¹IRCCS Casa Sollievo della Sofferenza, Italy; ²Università degli Studi di Foggia, Italy

  Elvira Grandone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.867

  22

  PDF: 10

• PO004 | SEX-RELATED DIFFERENCES AND PREDICTORS OF MORTALITY IN MAJOR ORTHOPEDIC SURGERY: INSIGHTS FROM THE ORTHO-START REGISTRY A. de Laurenzo¹, E. Antonucci², C. Rostagno³, D. Barcellona⁴, D. Colaizzo¹, G. di Rienzo⁵, F. Gorgoglione¹, G. Maccagnano⁶, F. Marongiu², M. Mastroianno¹, M. Marzolo⁷, L. Mirabella⁶, B. Moretti⁸, A.M. Moretti⁹, A. Ostuni⁶, G. Palareti², M. Margaglione⁶, E. Grandone^1|6 | ¹Fondazione I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni R. (Foggia), Italy; ²Fondazione Arianna, Bologna, Italy; ³Department of Internal and Postoperative Medicine, Careggi University Hospital, Firenze, Italy; ⁴Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; ⁵UOC Patologia Clinica-Ospedale Altamura ASL Bari, Italy; ⁶University of Foggia, Policlinico Riuniti Foggia, Italy; ⁷Angiology Unit, Ospedale di Rovigo, Rovigo, Italy; ⁸School of Medicine, AOU Consorziale Policlinico, University of Bari "Aldo Moro", Italy; ⁹President of GISeG (Italian Group for Health and Gender), Bari, Italy

  Elvira Grandone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.820

  22

  PDF: 8